Mesa Laboratories, Inc. Stock

$64.21

5.23%

Nasdaq, Sep 02, 10:00 pm CET

ISIN

US59064R1095

Symbol

MLAB

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P SmallCap 600

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Overview Dividends Analysts Charts News Strategies

Mesa Laboratories, Inc. Stock price

$64.21

-187.68 74.51% 5Y

Nasdaq, Closing price Tue, Sep 02 2025

-3.54 5.23%

ISIN

US59064R1095

Symbol

MLAB

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P SmallCap 600

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Key metrics

Basic

Market capitalization

$353.3m

Enterprise Value

$513.2m

Net debt

$159.9m

Cash

$21.3m

Shares outstanding

5.5m

Valuation (TTM | estimate)

P/E

negative | 34.0

P/S

1.5 | 1.4

EV/Sales

2.1 | 2.0

EV/FCF

15.2

P/B

2.1

Dividends

DPS

$0.64

Yield 1Y | 5Y

1.0% | 0.3%

Growth 1Y | 5Y

0.0% | 0.0%

Payout 1Y | 3Y

-177.8% | -4.1%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$242.4m | $253.9m

EBITDA

$30.8m | $60.3m

EBIT

$13.8m | $22.2m

Net Income

$-620.0k | $10.4m

Free Cash Flow

$33.7m

Growth (TTM | estimate)

Revenue

8.3% | 5.4%

EBITDA

10.2% | 83.6%

EBIT

58.8% | 36.1%

Net Income

99.8% | 627.9%

Free Cash Flow

-18.8%

Financial Health

Equity Ratio

36.9%

Return on Equity

-1.2%

ROCE

4.8%

ROIC

-0.2%

Debt/Equity

1.1

EPS

$-0.1

FCF per Share

$6.1

Short interest

10.6%

Employees

736

Rev per Employee

$330.0k

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Get Started for Free Today

Mesa Laboratories, Inc. Stock Analysis

Unlock Scores for Free

??

8 Analysts have issued a Mesa Laboratories, Inc. forecast:

3x Hold

38%

4x Sell

50%

More details on Analyst Estimates Including Price Targets

8 Analysts have issued a Mesa Laboratories, Inc. forecast:

Buy

13%

Hold

38%

Sell

50%

Analyst Estimates with Stock Price Targets

Financial data from Mesa Laboratories, Inc.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	242 242	8% 8% 100%
- Direct Costs	92 92	9% 9% 38%
Gross Profit	151 151	8% 8% 62%
- Selling and Administrative Expenses	100 100	9% 9% 41%
- Research and Development Expense	20 20	3% 3% 8%
EBITDA	31 31	10% 10% 13%
- Depreciation and Amortization	17 17	12% 12% 7%
EBIT (Operating Income) EBIT	14 14	59% 59% 6%
Net Profit	-0.62 -0.62	100% 100% 0%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Mesa Laboratories, Inc. Stock News

Neutral

GlobeNewsWire

●

16 days ago

Mesa Laboratories Executes Previously-Announced Strategic Financing Plan

LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company's 1.375% Convertible Senior Notes due August 2025 (the “2025 Notes”). On August 12, 2025, the Company drew $97.0 million unde...

Neutral

GlobeNewsWire

●

2 months ago

MESA LABS DECLARES QUARTERLY DIVIDEND

LAKEWOOD, Colo., July 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025.

Neutral

GlobeNewsWire

●

2 months ago

Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025

LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025.

More Mesa Laboratories, Inc. News

Company Profile

Mesa Laboratories, Inc. engages in the design, manufacture, and marketing of instruments and disposable products utilized in healthcare, pharmaceutical, food, and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection, Instruments, Cold Chain Monitoring, and Cold Chain Packaging. The Sterilization and Disinfection segment offers testing services, along with the manufacturing and marketing of biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. The Instrument segment manufactures and markets control instruments and disposable products. The Cold Chain Monitoring segment designs, develops, and markets systems which are used to monitor environmental parameters such as temperature, humidity, and differential pressure. The Cold Chain Packaging segment provides consulting services including compliance monitoring, packaging development, and validation or mapping of transport and storage containers, and thermal packaging products. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.

Head office	United States
CEO	Gary Owens
Employees	736
Founded	1982
Website	mesalabs.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now